News and Information

Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push

Xconomy Texas — March 30, 2016 Houston — Brett Giroir, the former head of Texas A&M University’s Health Science Center, has a new biotech venture in Houston, and has brought along innovation from his home state of Louisiana. Giroir has joined the board of Esperance Pharmaceuticals, a biotech developing drugs for a variety of cancers. Esperance was founded … Continue reading Houston Biotech Esperance Eyes $40M Raise to Fund Cancer Drug Push

Esperance Pharmaceuticals Names Brett Giroir MD to Board of Directors

Brings Unique Expertise and Perspective from Leadership Positions at Distinguished Academic, Government and Entrepreneurial Healthcare Institutions Company Opens Offices in Houston as EP-100 Advances in Ovarian and Breast Cancer Trials Conducted in Collaboration with MD Anderson Cancer Center Mar 17, 2016, 07:30 ET from Esperance Pharmaceuticals, Inc. HOUSTON, March 17, 2016 /PRNewswire/ -- Esperance Pharmaceuticals Inc. … Continue reading Esperance Pharmaceuticals Names Brett Giroir MD to Board of Directors

Baton Rouge cancer drug developer partners with MD Anderson

BY TED GRIGGS tgriggs@theadvocate.com AUG 29, 2015 - 5:04 PM A Baton Rouge cancer treatment startup has drawn the attention of MD Anderson Cancer Center and a deal to accelerate development of the company’s lead anti-cancer drug. Under the agreement with Esperance Pharmaceuticals Inc., Houston-based MD Anderson will conduct additional studies to help prepare for … Continue reading Baton Rouge cancer drug developer partners with MD Anderson

Esperance Announces Strategic Alliance with MD Anderson Cancer Center

Esperance and MD Anderson Will Collaborate to Accelerate Development of EP-100 in Ovarian and Breast Cancer Aug 24, 2015, 07:30 ET from Esperance Pharmaceuticals, Inc. BATON ROUGE, La., Aug. 24, 2015 /PRNewswire/ -- Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead … Continue reading Esperance Announces Strategic Alliance with MD Anderson Cancer Center

New Investor Technology to Provide Insights into Investing in Private Companies

Platform Resulted from Collaboration by Investment Data and Software Development Industry Leaders Aug 18, 2015, 06:00 ET from VC Experts SHREVEPORT, La., Aug. 18, 2015 /PRNewswire/ -- VC Experts, a data aggregator of privately held companies, and Switchback Partners, a software development team based in Austin, Texas that specializes in stock market trading and analytic platforms, join to reduce inefficiencies in the … Continue reading New Investor Technology to Provide Insights into Investing in Private Companies

K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers

--New Company Is Leveraging Discoveries and Expertise of Cancer Researchers at LSU's Pennington Biomedical Research Center and Feist Weiller Cancer Center-- Sep 24, 2013, 07:30 ET from K94 Discoveries, Inc. BATON ROUGE, La., Sept. 24, 2013 /PRNewswire/ -- K94 Discoveries, Inc., (K94) a new biotechnology company applying hormone receptor-targeting technology to develop novel cancer therapies, today … Continue reading K94 Discoveries, Inc. Announces Seed Financing To Advance Targeted Drug Conjugates To Treat Pancreatic And Other Cancers

ArborGen Poised for Growth with Acquisition of CellFor’s Varietal Business

RIDGEVILLE, S.C.--(BUSINESS WIRE)--ArborGen, the world leader in the development and commercialization of technologies that improve the productivity of trees, and the world’s largest provider of loblolly pine seedlings, today announced the completion of its acquisition of the primary assets of CellFor Inc., a leading supplier of elite varietal pine tree seedlings to foresters in the … Continue reading ArborGen Poised for Growth with Acquisition of CellFor’s Varietal Business

Ringing the Bell at NY Stock Exchange

Ross P. Barrett of BVM Capital, LLC and Members of the Louisiana Committee of 100 ringing the closing bell of the NYSE on November 18, 2010. From left to right include David Smallman (LED Consultant), Robert Shreve (Gulf South Business Systems), John Blackman (Jones Walker), Michael Olivier (C100), Mary Leach Werner (Chalkley Companies), Randy Ewing … Continue reading Ringing the Bell at NY Stock Exchange

CellFor Announces the Completion of a $35 Million Equity Financing

BusinessWire - July 15, 2010 CellFor Inc., the leading provider of non-GMO elite tree varieties for reforestation, announced the closing of a new equity financing in excess of U.S. $35 Million. “This is a tremendous acknowledgement of CellFor’s progress to date and the significant opportunities available to us in the near term,” commented Tom Urban, … Continue reading CellFor Announces the Completion of a $35 Million Equity Financing